CD274 and cancer: In summary, we discover a new role of FBP1 in antagonizing STAT3-dependent expression of PD-L1 and the mechanism through which FBP1 loss in human cancer cells contributes to the upregulation of PD-L1 and resistance to anti-PD-L1 treatment.